Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.
Show more...
FAQ
Organicell Regenerative Medicine 今天的股价是多少?▼
BPSR 当前价格为 $0.06 USD,过去 24 小时上涨了 +22.45%。在图表上更密切关注 Organicell Regenerative Medicine 股价表现。
Organicell Regenerative Medicine 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Organicell Regenerative Medicine 的股票以代码 BPSR 进行交易。
Organicell Regenerative Medicine 的市值是多少?▼
今天 Organicell Regenerative Medicine 的市值为 66.15M
Organicell Regenerative Medicine 上一季度的财报怎么样?▼
BPSR 上季度财报为每股 -0 USD,预估为 不适用 USD,带来 不适用 的意外。下季度预估财报为每股 不适用 USD。
Organicell Regenerative Medicine 去年的营收是多少?▼
Organicell Regenerative Medicine 去年的营收为 6.49MUSD。
Organicell Regenerative Medicine 去年的净利润是多少?▼
BPSR 去年的净收益为 -8.9MUSD。
Organicell Regenerative Medicine 有多少名员工?▼
截至四月 02, 2026,公司共有18名员工。
Organicell Regenerative Medicine 属于哪个行业?▼
Organicell Regenerative Medicine从事于Professional, Scientific, and Technical Services行业。
Organicell Regenerative Medicine 何时完成拆股?▼
Organicell Regenerative Medicine 上次拆股发生在 九月 21, 2015,比例为 18:1。